Multidrug- resistant genotypes of plasmodium falciparum, Myanmar

Emerging Infectious Diseases

Volumn 17, Issue 3, 2011, Pages 498-501

  Yang, Zhaoqing ^a   Li, Chaoqun ^a   Miao, Miao ^a,c   Zhang, Zaixing ^b   Sun, Xiaodong ^b   Meng, Hao ^c   Li, Jie ^a   Fan, Qi ^d   Cui, Liwang ^a,c  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b Yunnan Institute of Parasitic Diseases   (China)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d Dalian Institute of Education   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER; PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE; PLASMODIUM FALCIPARUM DIHYDROPOTEROATE SYNTHASE; PLASMODIUM FALCIPARUM MULTIDRUG RESISTANCE 1; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG;

ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CODON; FEVER; GENE MUTATION; GENOTYPE; HAPLOTYPE; HUMAN; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; MYANMAR; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTIMALARIALS; DRUG RESISTANCE, MULTIPLE; GENOTYPE; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; MOLECULAR EPIDEMIOLOGY; MUTATION; MYANMAR; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PREVALENCE; PROTOZOAN PROTEINS; QUININE;

EID: 79952340011     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1703.100870     Document Type: Article

References (15)

1. Socheat D, Denis MB, Fandeur T, Zhang Z, Yang H, Xu J, et al. Mekong malaria. II. Update of malaria, multi-drug resistance and economic development in the Mekong region of Southeast Asia. Southeast Asian J Trop Med Public Health. 2003;34(Suppl 4):1-102.
2. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature. 2002;418:320-3. DOI: 10.1038/nature00813
3. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004;305:1124. DOI: 10.1126/science.1098876
4. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619-20. DOI: 10.1056/NEJMc0805011
5. Meng H, Zhang R, Yang H, Fan Q, Su X, Miao J, et al. In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger. Antimicrob Agents Chemother. 2010;54:4306-13. DOI: 10.1128/AAC.00321-10
6. Yang Z, Zhang Z, Sun X, Wan W, Cui L, Zhang X, et al. Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province, China. Trop Med Int Health. 2007;12:1051-60. DOI: 10.1111/j.1365-3156.2007.01882.x
7. Henry M, Briolant S, Zettor A, Pelleau S, Baragatti M, Baret E, et al. Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrob Agents Chemother. 2009;53:1926-30. DOI: 10.1128/AAC.01243-08
8. Okombo J, Kiara SM, Rono J, Mwai L, Pole L, Ohuma E, et al. In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya. Antimicrob Agents Chemother. 2010;54:3302-7. DOI: 10.1128/AAC.00325-10
9. Andriantsoanirina V, Menard D, Rabearimanana S, Hubert V, Bouchier C, Tichit M, et al. Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confi rmation in clinical isolates from Africa. Am J Trop Med Hyg. 2010;82:782-7. DOI: 10.4269/ajtmh.2010.09-0327
10. Ferdig MT, Cooper RA, Mu J, Deng B, Joy DA, Su XZ, et al. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol Microbiol. 2004;52:985-97. DOI: 10.1111/j.1365- 2958.2004.04035.x
11. Smithuis FM, Monti F, Grundl M, Oo AZ, Kyaw TT, Phe O, et al. Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefl oquine in western Myanmar. Trans R Soc Trop Med Hyg. 1997;91:468-72. DOI: 10.1016/S0035- 9203(97)90288-1
12. Smithuis F, Shahmanesh M, Kyaw MK, Savran O, Lwin S, White NJ. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefl oquine and mefl oquine-artesunate for the treatment of falciparum malaria in Kachin State, north Myanmar. Trop Med Int Health. 2004;9:1184-90. DOI: 10.1111/j.1365-3156.2004.01323.x
13. Wongsrichanalai C, Lin K, Pang LW, Faiz MA, Noedl H, Wimonwattrawatee T, et al. In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs. Am J Trop Med Hyg. 2001;65:450-5.
14. Khim N, Bouchier C, Ekala MT, Incardona S, Lim P, Legrand E, et al. Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia. Antimicrob Agents Chemother. 2005;49:3147-52. DOI: 10.1128/ AAC.49.8.3147-3152.2005
15. Anderson TJ, Nair S, Sudimack D, Williams JT, Mayxay M, Newton PN, et al. Geographical distribution of selected and putatively neutral SNPs in Southeast Asian malaria parasites. Mol Biol Evol. 2005;22:2362-74. DOI: 10.1093/molbev/msi235